Diflucortolone valerate (BAY866146)

Pre-clinicalCompleted

0 views this week 0 watching💤 Quiet

Interest: 23/100

Hype Score

Development Stage

Pre-clinical

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Relationship Between the Exposure of Glucocorticoids During Pregnancy and Orofacial Cleft Development

Conditions

Relationship Between the Exposure of Glucocorticoids During Pregnancy and Orofacial Cleft Development

Trial Timeline

Nov 16, 2018 → Nov 29, 2018

NCT ID

NCT03788863

About Diflucortolone valerate (BAY866146)

Diflucortolone valerate (BAY866146) is a pre-clinical stage product being developed by Bayer for Relationship Between the Exposure of Glucocorticoids During Pregnancy and Orofacial Cleft Development. The current trial status is completed. This product is registered under clinical trial identifier NCT03788863. Target conditions include Relationship Between the Exposure of Glucocorticoids During Pregnancy and Orofacial Cleft Development.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT03788863	Pre-clinical	Completed	Nov 16, 2018	Nov 29, 2018	Relationship Between the Exposure of Glucocorticoids During Pregnancy and Orofacial Cleft Development